HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laser in situ keratomileusis for hyperopia.

AbstractOBJECTIVE:
To evaluate laser in situ keratomileusis (LASIK) ablation zone size and its relationship to refractive and visual outcomes in the treatment of hyperopia.
METHODS:
We evaluated retrospectively 40 eyes of 20 patients who had LASIK: 20 eyes had a refractive ablation zone ranging from 5.5 to 9.0 mm (Group 1); Group 2 consisted of 20 eyes with a refractive ablation zone from 5.5 to 8.25 mm. We used the Nidek EC-5000 excimer laser and the Hansatome microkeratome. Mean spherical equivalent refraction was +2.72 D in Group 1 and +2.75 D in Group 2. Objective refraction and visual acuity were evaluated over 6 months in both groups.
RESULTS:
Six months after LASIK, mean spherical equivalent refraction in Group 1 was +1.00 +/- 0.84 D and in Group 2 it was +0.75 +/- 0.42 D. One patient in Group 1 lost 1 line of spectacle-corrected visual acuity; none in Group 2 lost lines. Six patients gained 1 to 3 lines from their preoperative spectacle-corrected visual acuity.
CONCLUSIONS:
LASIK provides good results for mild and moderate hyperopia. LASIK with an ablation zone from 5.5 to 8.25 mm showed better predictability and more stable results. However, corneal diameter and the thickness and width of the flap appear to be important factors in the feasibility of LASIK in hyperopic eyes.
AuthorsD S Rosa, J L Febbraro
JournalJournal of refractive surgery (Thorofare, N.J. : 1995) (J Refract Surg) 1999 Mar-Apr Vol. 15 Issue 2 Suppl Pg. S212-5 ISSN: 1081-597X [Print] United States
PMID10202723 (Publication Type: Comparative Study, Journal Article)
Topics
  • Adult
  • Cornea (pathology, surgery)
  • Corneal Topography
  • Corneal Transplantation (methods, pathology)
  • Eyeglasses
  • Female
  • Follow-Up Studies
  • Humans
  • Hyperopia (pathology, surgery)
  • Laser Therapy
  • Male
  • Patient Satisfaction
  • Postoperative Complications
  • Refraction, Ocular
  • Retrospective Studies
  • Treatment Outcome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: